Quest Diagnostics, Inc. (DGX)
243.87
-0.52
(-0.21%)
USD |
NYSE |
Aug 24, 16:00
243.86
-0.01
(-0.00%)
After-Hours: 20:00
Quest Diagnostics EPS Diluted (Quarterly) : 2.848 for June 30, 2026
EPS Diluted (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical EPS Diluted (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2026 | 2.848 |
| March 31, 2026 | 2.241 |
| December 31, 2025 | 2.188 |
| September 30, 2025 | 2.150 |
| June 30, 2025 | 2.487 |
| March 31, 2025 | 1.938 |
| December 31, 2024 | 1.947 |
| September 30, 2024 | 1.991 |
| June 30, 2024 | 2.036 |
| March 31, 2024 | 1.723 |
| December 31, 2023 | 1.699 |
| September 30, 2023 | 1.956 |
| June 30, 2023 | 2.053 |
| March 31, 2023 | 1.779 |
| December 31, 2022 | 0.8783 |
| September 30, 2022 | 2.152 |
| June 30, 2022 | 1.958 |
| March 31, 2022 | 2.926 |
| December 31, 2021 | 3.112 |
| September 30, 2021 | 4.024 |
| June 30, 2021 | 4.945 |
| March 31, 2021 | 3.467 |
| December 31, 2020 | 4.204 |
| September 30, 2020 | 4.131 |
| June 30, 2020 | 1.353 |
| Date | Value |
|---|---|
| March 31, 2020 | 0.7333 |
| December 31, 2019 | 1.853 |
| September 30, 2019 | 1.562 |
| June 30, 2019 | 1.662 |
| March 31, 2019 | 1.198 |
| December 31, 2018 | 0.92 |
| September 30, 2018 | 1.53 |
| June 30, 2018 | 1.576 |
| March 31, 2018 | 1.27 |
| December 31, 2017 | 1.82 |
| September 30, 2017 | 1.143 |
| June 30, 2017 | 1.379 |
| March 31, 2017 | 1.16 |
| December 31, 2016 | 1.099 |
| September 30, 2016 | 1.34 |
| June 30, 2016 | 1.37 |
| March 31, 2016 | 0.7153 |
| December 31, 2015 | 1.306 |
| September 30, 2015 | 2.345 |
| June 30, 2015 | 0.81 |
| March 31, 2015 | 0.42 |
| December 31, 2014 | 1.301 |
| September 30, 2014 | 0.88 |
| June 30, 2014 | 0.92 |
| March 31, 2014 | 0.71 |
EPS Diluted (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
EPS Diluted (Quarterly) Benchmarks
| Labcorp Holdings, Inc. | 3.643 |
| DaVita, Inc. | 4.016 |
| OPKO Health, Inc. | -0.0111 |
| Psychemedics Corp. | -- |
| NeoGenomics, Inc. | 0.0171 |
EPS Diluted (Quarterly) Related Metrics
| Net Income (Quarterly) | 333.00M |
| Revenue (Quarterly) | 3.043B |
| Total Expenses (Quarterly) | 2.724B |
| Enterprise Value | 32.97B |
| Gross Profit Margin (Quarterly) | 32.53% |
| Profit Margin (Quarterly) | 10.94% |
| Earnings Yield | 3.87% |
| Operating Earnings Yield | 6.15% |
| Normalized Earnings Yield | 4.096 |